These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22998750)

  • 21. Histopathological correlations of islet amyloidosis with apolipoprotein E polymorphisms in type 2 diabetic Chinese patients.
    Guan J; Zhao HL; Sui Y; He L; Lee HM; Lai FM; Tong PC; Chan JC
    Pancreas; 2013 Oct; 42(7):1129-37. PubMed ID: 24005233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. γ-Secretase-mediated regulation of neprilysin: influence of cell density and aging and modulation by imatinib.
    Bauer C; Pardossi-Piquard R; Dunys J; Roy M; Checler F
    J Alzheimers Dis; 2011; 27(3):511-20. PubMed ID: 21841248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
    Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats.
    Shiba M; Suzuki H; Fujimoto M; Shimojo N; Imanaka-Yoshida K; Yoshida T; Kanamaru K; Matsushima S; Taki W
    Neurobiol Dis; 2012 Apr; 46(1):172-9. PubMed ID: 22300707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
    Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K
    Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolated amyloidosis of the islands of Langerhans and diabetic mellitus].
    Panova NV; Tsvetkov OV; Lebedeva AN; Proskurneva EP
    Arkh Patol; 1994; 56(1):77-9. PubMed ID: 8204060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.
    Distler JH; Manger B; Spriewald BM; Schett G; Distler O
    Arthritis Rheum; 2008 Aug; 58(8):2538-42. PubMed ID: 18668536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Age-related amyloidosis of the pancreatic islets and diabetes mellitus].
    Zykova LD; Serov VV; Sekamova SM
    Klin Med (Mosk); 1988 Dec; 66(12):80-4. PubMed ID: 3068412
    [No Abstract]   [Full Text] [Related]  

  • 30. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.
    Schittenhelm MM; Shiraga S; Schroeder A; Corbin AS; Griffith D; Lee FY; Bokemeyer C; Deininger MW; Druker BJ; Heinrich MC
    Cancer Res; 2006 Jan; 66(1):473-81. PubMed ID: 16397263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib mesylate: A designer drug.
    Panigrahi I; Naithani R
    J Assoc Physicians India; 2006 Mar; 54():203-6. PubMed ID: 16800347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism.
    Cataldi M; Gaudino A; Lariccia V; Russo M; Amoroso S; di Renzo G; Annunziato L
    J Pharmacol Exp Ther; 2004 Apr; 309(1):208-15. PubMed ID: 14718589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic islet fibrosis in rock hyrax (Procavia capensis), Part 2: Pathology, immunohistochemistry, and electron microscopy.
    Garner MM; Gamble KC; Raymond JT; Alvarado TP; Wojcieszyn JW; Nordhausen RW
    J Zoo Wildl Med; 2004 Sep; 35(3):280-91. PubMed ID: 15526882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet amyloidosis in a child with type 1 diabetes.
    Beery ML; Jacobsen LM; Atkinson MA; Butler AE; Campbell-Thompson M
    Islets; 2019; 11(2):44-49. PubMed ID: 31084520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR
    J Cardiometab Syndr; 2007; 2(1):70-5. PubMed ID: 17684452
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreatic abnormalities in type 2 diabetes mellitus.
    Lancet; 1987 Dec; 2(8574):1497-8. PubMed ID: 2892052
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreatic islet fibrosis in rock hyraxes (Procavia capensis), Part 1: Case histories, clinical pathology, and epizootiology.
    Gamble KC; Garner MM; Krause L; Alvarado TP
    J Zoo Wildl Med; 2004 Sep; 35(3):361-9. PubMed ID: 15526892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.